MCID: END057
MIFTS: 75

Endometrial Cancer malady

Categories: Genetic diseases, Rare diseases, Cancer diseases, Reproductive diseases

Aliases & Classifications for Endometrial Cancer

About this section

Aliases & Descriptions for Endometrial Cancer:

Name: Endometrial Cancer 51 47 69 12 49
Endometrial Carcinoma 11 26 12 49 13 67
Endometrial Carcinoma, Somatic 51 24
Carcinoma, Endometrioid 38 67
Endometrial Neoplasms 38 67
Endometrioid Carcinoma of Female Reproductive System 11
 
Malignant Neoplasm of Endometrium 67
Endometrial Cancer, Familial 51
Carcinoma of the Endometrium 11
Endometrioid Carcinoma 11
Uterine Corpus Cancer 67
Endmc 69

Classifications:



External Ids:

OMIM51 608089
Disease Ontology11 DOID:2871
NCIt44 C3769, C7558
MedGen36 C0476089
ICD1029 C54.1

Summaries for Endometrial Cancer

About this section
UniProtKB/Swiss-Prot:69 Endometrial cancer: A malignancy of endometrium, the mucous lining of the uterus. Most endometrial cancers are adenocarcinomas, cancers that begin in cells that make and release mucus and other fluids.

MalaCards based summary: Endometrial Cancer, also known as endometrial carcinoma, is related to adenomyosis and adenosquamous carcinoma, and has symptoms including endometrial carcinoma An important gene associated with Endometrial Cancer is PTEN (Phosphatase And Tensin Homolog), and among its related pathways are Mismatch repair and Vemurafenib Pathway, Pharmacodynamics. The drugs medroxyprogesterone and cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include the tissue lining the uterus, uterus and lymph node, and related mouse phenotypes are hearing/vestibular/ear and pigmentation.

Disease Ontology:11 A endometrial cancer that is located in the tissue lining the uterus.

Wikipedia:70 Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It... more...

Description from OMIM:51 608089

Related Diseases for Endometrial Cancer

About this section

Diseases related to Endometrial Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 287)
idRelated DiseaseScoreTop Affiliating Genes
1adenomyosis31.4CTNNB1, EGFR, ERBB2
2adenosquamous carcinoma30.9EGFR, ERBB2, KRAS, PIK3CA
3breast cancer30.9CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
4colorectal cancer30.3CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
5uterine corpus endometrial carcinoma11.8
6lynch syndrome11.3
7polycystic ovary syndrome11.2
8large intestine adenocarcinoma11.1MLH1, MSH2, MSH6
9colver steer godman syndrome11.1CDH1, MLH1, MSH2, TP53
10neuropathy, distal hereditary motor, type viib11.1MLH1, MSH2, MSH6
11gelatinous ascites11.1ERBB2, ESR1, PGR
12hereditary essential tremor 511.1KRAS, MLH1, MSH2, MSH6
13sleeping sickness11.1MLH1, MSH3, MSH6
14amyloid tumor11.1CCND1, ESR1, PGR, PTEN
15angioimmunoblastic lymphadenopathy with dysproteinemia11.1EGF, MLH1, MSH2
16glottis verrucous carcinoma11.1EGFR, ERBB2, ESR1, PGR
17spleen angiosarcoma11.1EGF, ESR1, MLH1, MSH2, MSH6
18bladder colonic type adenocarcinoma11.1EGFR, ERBB2, ESR1, PGR
19ossifying fibromyxoid tumor11.1EGFR, ERBB2, PGR
20mismatch repair cancer syndrome11.1CTNNB1, MLH1, MSH2, MSH6, PTEN
21cervical adenomyoma11.1CTNNB1, MLH1, MSH2
22cholesteatoma of external ear11.1ERBB2, ESR1, PGR, TP53
23trigeminal nerve disease11.1ERBB2, ESR1, PGR
24animal phobia11.1EGFR, ERBB2, PGR, TP53
25her2-receptor negative breast cancer11.1EGFR, ERBB2, PGR
26cell type benign neoplasm11.1ERBB2, ESR1, PGR, TP53
27cartilage cancer11.1ERBB2, ESR1, PGR, TP53
28adenocarcinoma in situ11.1ERBB2, ESR1, PGR
29anomalous left coronary artery from the pulmonary artery11.1EGFR, ERBB2, ESR1, PGR
30leiomyosarcoma11.1ERBB2, ESR1, PGR, TP53
31optic papillitis11.1CCND1, KRAS, MLH1, MSH2, MSH6
32pyoderma11.1KRAS, MLH1, PIK3CA, TP53
33gastric squamous cell carcinoma11.1CDH1, EGFR, ERBB2
34breast adenoma11.1ERBB2, ESR1, PGR, TP53
35bartholin's gland adenoid cystic carcinoma11.1EGFR, ESR1, PGR
36tamoxifen-related endometrial lesion11.1EGFR, PIK3CA, TP53
37tumor predisposition syndrome11.1CDH1, MLH1, MSH2, MSH6, PTEN, TP53
38nerve fibre bundle defect11.1ERBB2, ESR1, PGR, TP53
39food allergy11.1MLH1, MSH2, MSH6
40vulval paget's disease11.1ERBB2, ESR1, PGR, TP53
41pleomorphic carcinoma11.1EGFR, ERBB2, ESR1, PGR
42gallbladder squamous cell carcinoma11.1CCND1, ESR1, PGR
43uterine body mixed cancer11.1ESR1, PGR, TP53
44breast papillary carcinoma11.1EGFR, ERBB2, KRAS, PIK3CA
45cerebellar disease11.1CTNNB1, KRAS, MLH1, MSH2, MSH6
46integumentary system cancer11.1CCND1, CDH1, EGFR, TP53
47distal monosomy 9p11.1EGFR, ERBB2, PGR, TP53
48fallopian tube mucinous adenocarcinoma11.1EGFR, ERBB2, ESR1, TP53
49mixed cerebral palsy11.1ERBB2, ESR1, PGR, TP53
50lung carcinoma in situ11.1ERBB2, ESR1, PGR, TP53

Graphical network of the top 20 diseases related to Endometrial Cancer:



Diseases related to endometrial cancer

Symptoms for Endometrial Cancer

About this section


Clinical features from OMIM:

608089

Human phenotypes related to Endometrial Cancer:

 63
id Description HPO Frequency HPO Source Accession
1 endometrial carcinoma63 HP:0012114

Drugs & Therapeutics for Endometrial Cancer

About this section

Drugs for Endometrial Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 430)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Estradiolapproved, investigational, vet_approvedPhase 4, Phase 2, Phase 3, Early Phase 1128350-28-25757, 53477783
Synonyms:
(+)-3,17b-Estradiol
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17beta)-Estra-1,3,5(10)-triene-3,17-diol
.alpha.-Estradiol
.alpha.-Oestradiol
.beta.-Estradiol
.beta.-Oestradiol
1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate
1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate
13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol
17 beta-Estradiol
17-.BETA.-Estradiol
17-E
17-beta
17-beta-OH-estradiol
17-beta-estradiol
17.beta.-Estradiol
17.beta.-Oestradiol
17E
17b-Estradiol
17b-Oestradiol
17beta Oestradiol
17beta oestradiol
17beta-Estra-1,3,5(10)-triene-3,17-diol
17beta-Estradiol
17beta-Oestradiol
1jgl
1qkt
1qku
2d06
3,17-Epidihydroxyestratriene
3,17-beta-Estradiol
3,17-beta-Oestradiol
3,17.beta.-Estradiol
3,17b-Dihydroxyestra-1,3,5(10)-triene
3,17b-Estradiol
3,17beta-Estradiol
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate
50-28-2
73459-61-7
873662-39-6
AC-10460
AC1L1L2K
Aerodiol
Agofollin
Alora
Altrad
Amnestrogen
Aquadiol
B-Estradiol
BEDOs
BIDD:ER0125
BIDD:PXR0065
BPBio1_000532
BSPBio_000482
BSPBio_001065
Bardiol
Benzhormovarine
Beta-estradiol
Bio-0812
Bio-E-Gel
Bio1_000403
Bio1_000892
Bio1_001381
Bio2_000363
Bio2_000843
C00951
C18H24O2
CCRIS 280
CHEBI:16469
CHEMBL135
CID5757
CMC_11154
CPD-352
CPD000059126
Climaderm
Climara
Climara (TN)
Climara Forte
Compudose
Compudose 200
Compudose 365
Corpagen
D-3,17beta-Estradiol
D-Estradiol
D-Oestradiol
D00105
DB00783
Dermestril
Destradiol
Dihydro-Theelin
Dihydrofollicular hormone
Dihydrofolliculin
Dihydromenformon
Dihydrotheelin
Dihydroxyesterin
Dihydroxyestrin
Dihydroxyoestrin
Dimenformon
Diogyn
Diogynets
Divigel
Divigel (TN)
E 2
E 8875
E(sub 2)
E0025
E1024_SIGMA
E1132_SIGMA
E2257_SIGMA
E2758_SIGMA
E8875_SIGMA
EINECS 200-023-8
EU-0100503
Elestrin
Encore
Epiestriol 50
Esclim
Estra-1,3,5(10)-triene-3,17b-diol
Estrace
Estrace (TN)
Estraderm
Estraderm (TN)
Estraderm MX
Estraderm TTS
Estraderm TTS 100
Estraderm TTS 50
Estradiol
Estradiol [USAN:INN]
Estradiol-17 beta
Estradiol-17-beta
Estradiol-17.beta.
Estradiol-17beta
Estradiol-3,17beta
Estradiolo
Estradiolo [DCIT]
Estradiolum
Estradiolum [INN]
Estradot
Estraldine
Estrapak 50
Estrasorb
Estrasorb (TN)
Estreva
Estrifam
Estring
Estring (TN)
Estring Vaginal Ring
Estring vaginal ring
Estroclim
Estroclim 50
Estrodiolum
Estrofem 2
Estrofem Forte
Estrogel
 
Estrogel (TN)
Estrogel HBF
Estrovite
Evamist
Evorel
Extrasorb
Femanest
Femestral
Femestrol
Femogen
Fempatch
Femtrace
Femtran
Follicyclin
Gelestra
Ginedisc
Ginosedol
GynPolar
Gynergon
Gynestrel
Gynodiol
Gynoestryl
HMS1362E07
HMS1569I04
HMS1792E07
HMS1990E07
HMS2051C17
HMS2090E18
HSDB 3589
IDI1_002118
Innofem
Innofem (TN)
KBio2_000405
KBio2_002269
KBio2_002973
KBio2_004837
KBio2_005541
KBio2_007405
KBio3_000769
KBio3_000770
KBio3_002749
KBioGR_000405
KBioGR_002269
KBioSS_000405
KBioSS_002270
LMST02010001
LS-137
Lamdiol
Lio-Oid
Lopac0_000503
MLS000069494
MLS000758312
MLS001076331
Macrodiol
Macrol
Menest
Menorest
Menostar
Microdiol
MolPort-001-794-632
NCGC00091544-00
NCGC00091544-01
NCGC00091544-02
NCGC00091544-04
NCGC00091544-05
NCGC00091544-06
NCGC00091544-07
NCGC00091544-08
NCGC00091544-09
NCGC00091544-12
NCGC00179321-01
NCGC00179321-02
NSC-9895
NSC9895
Nordicol
Oesclim
Oestergon
Oestra-1,3,5(10)-triene-3,17b-diol
Oestradiol
Oestradiol Berco
Oestradiol R
Oestradiol-17-beta
Oestradiol-17.beta.
Oestradiol-17beta
Oestradiolum
Oestrogel
Oestroglandol
Oestrogynal
Ovahormon
Ovasterol
Ovastevol
Ovociclina
Ovocyclin
Ovocycline
Ovocylin
Perlatanol
Polyestradiol
Prestwick0_000441
Prestwick1_000441
Prestwick2_000441
Prestwick3_000441
Prestwick_207
Primofol
Profoliol
Profoliol B
Progynon
Progynon DH
Progynon-DH
S-21400
S1709_Selleck
SAM001247032
SK-Estrogens
SL-1100
SMP1_000121
SMR000059126
SPBio_002421
Sandrena 1
Sandrena Gel
Sisare Gel
Spectrum5_002055
Syndiol
Systen
Tradelia
Trial SAT
Trocosone
UNII-4TI98Z838E
VIVELLE-DOT
Vagifem
Vagifem (TN)
Vivelle
Vivelle (TN)
Zerella
Zesteem
Zesteen
Zumenon
[2,4,6,7-3H]-E2
[3H]-estradiol
[3H]]estradiol
b-Estradiol
beta-Estradiol
beta-Estradiol 3-sulfate
beta-Estradiol 3-sulphate
bmse000642
cMAP_000005
cis-Estradiol
cis-Oestradiol
component of Menrium
delta-Estradiol
delta-Oestradiol
estradiol
estradiol-17beta
nchembio.168-comp3
nchembio.76-comp2
nchembio775-comp2
nchembio794-comp6
nchembio860-comp1
progynon
2
Medroxyprogesterone acetateapproved, investigationalPhase 4, Phase 3, Phase 214571-58-9
Synonyms:
(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione
17-Acetoxy-6alpha-methylprogesterone
17-Acetoxy-6α-methylprogesterone
17alpha-Hydroxy-6alpha-methylprogesterone acetate
17α-hydroxy-6α-methylprogesterone acetate
6-alpha-Methyl-17-alpha-acetoxyprogesterone
6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate
6alpha-Methyl-17-acetoxy progesterone
 
6alpha-Methyl-17alpha-hydroxyprogesterone acetate
6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate
6α-Methyl-17-acetoxy progesterone
6α-Methyl-17α-hydroxyprogesterone acetate
MPA
Medroxyacetate progesterone
Medroxyprogesterone 17-acetate
Medroxyprogesterone acetate
Methylacetoxyprogesterone
Metigestrona
3
Levonorgestrelapproved, investigationalPhase 4, Phase 3, Phase 2293797-63-7, 17489-40-613109
Synonyms:
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
(-)-Norgestrel
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one
)-Norgestrel
121714-72-5
13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE
13-Ehyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one
13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one
13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one
13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one
13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
17-Ethynyl-18-methyl-19-nortestosterone
17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one
17-alpha-Ethynyl-13-ethyl-19-nortestosterone
17alpha-Ethynyl-13-ethyl-19-nortestosterone
17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17alpha-Ethynyl-18-homo-19-nor-testosterone
17alpha-Ethynyl-18-homo-19-nortestosterone
17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one
18,19-Dinor-4-pregnen-20-yn-3-one
18-Methyl-17-alpha-ethynyl-19-nortestosterone
18-Methylnorethisterone
4222-79-1
6533-00-2
72-HOURS
797-62-6
797-63-7
AC1L211U
AC1Q6OEV
BAY 86-5028
BAY86-5028
BIDD:PXR0194
BPBio1_000932
BRD-K35189033-001-03-0
BRN 2391114
BSPBio_000846
Bio-0595
C08149
C08153
CCRIS 6525
CCRIS 9033
CHEBI:44593
CHEBI:6443
CHEMBL1389
CID13109
CPD000059117
Capronor
D(−
D(-)-Norgestrel
D-(-)-Norgestrel
D-Norgestrel
D00950
D00954
DB00367
DB00506
E-Gen-C
EINECS 212-349-8
EINECS 229-433-5
FH 122-A
Follistrel
HMS1570K08
HMS2051M08
HMS2090O06
HSDB 3595
HSDB 6483
Jadelle
LD norgestrel [French]
LMST02030119
LO/Ovral
LS-62083
LS-62084
Ld norgestrel
Levlen
Levlen ED
Levonelle
Levonelle, D-Norgestrel, Levonova, Levonorgestrel
Levonorgestrel
Levonorgestrel (JAN/USP/INN)
Levonorgestrel [USAN:INN:BAN]
Levonorgestrel implants
Levonorgestrelum
Levonorgestrelum [INN-Latin]
Levonova
Levora-21
Levora-28
Logynon ED
Lévonorgestrel
MLS000069491
MLS000759484
 
MLS001074069
Methylnorethindrone
Microgest ED
Microgyn
Microgynon 21
Microgynon 28
Microgynon 30 ED
Microgynon CD
Microlut
Microlution
Microluton
Microval
Minivlar 30
Mirena
Mirena (TN)
MolPort-002-510-453
Monofeme 28
Monovar
N2260_FLUKA
N2260_SIGMA
NCGC00159349-02
NCGC00159349-03
NORPLANT
NSC744007
Neogest
Neogynon 21
NorLevo
Nordet
Nordette 21
Nordette 28
Norgeston
Norgestrel (JP15/USP/INN)
Norgestrel [Progestins]
Norgestrel [USAN:BAN:INN:JAN]
Norgestrel [USAN:INN:BAN:JAN]
Norgestrel-(-)-D
Norgestrelum
Norgestrelum [INN-Latin]
Norplant (TN)
Norplant 2
Norplant II
Norplant System in Plastic Container
Norplant-2
Ovoplex 30-150
Ovral-Lo
Ovranette
Ovrette
Ovrette (TN)
Plan B
Plan b
Postinor
Postinor-2
Prestwick0_000773
Prestwick1_000773
Prestwick2_000773
Prestwick3_000773
Prestwick_109
Preven
Rigevidon 21+7
S1727_Selleck
SAM001246694
SH 70850
SH 850
SMR000059117
SMR000653526
SOH-075
SPBio_002785
Stediril 30
Tetragynon
Tri-Levlen 21
Triagynon
Triciclor
Trifeme 28
Trigoa
Trinordiol 21
Trinordiol 28
Triphasil 21
Triphasil 28
Triquilar ED
Trivora
UNII-3J8Q1747Z2
UNII-5W7SIA7YZW
Wy 3707
Wy-3707
Wy-5104
ZINC03814395
alpha-Norgestrel
component of Lo/ovral
d(-)-Norgestrel
dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone
dl-Norgestrel
norgestrel
4
Letrozoleapproved, investigationalPhase 4, Phase 3, Phase 2, Early Phase 1382112809-51-53902
Synonyms:
1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole
1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole
112809-51-5
4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)
4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile
4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-Benzonitrile Letrozole
4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile
4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile
4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile
4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
AB00514009
AC-1193
AC1L1GYT
AKOS005145822
BIDD:GT0015
BIDD:PXR0130
BPBio1_001331
BRD-K88789588-001-03-2
BSPBio_001209
Bio-0057
C067431
C08163
C17H11N5
CAS-112809-51-5
CCRIS 8822
CGS 20267
CGS 20267, Femara, Piroxicam, Letrozole
CGS-20267
CHEBI:6413
CHEMBL1444
CID3902
CPD000466343
D00964
 
DB01006
FEM-345
Femara
Femara (TN)
Femera
HMS1571M11
HMS2051E08
HMS2089L22
HSDB 7461
I06-0022
LS-38788
Letoval
Letrozol
Letrozole
Letrozole (JAN/USP/INN)
Letrozole [USAN:INN]
MLS000759455
MLS001424038
MLS002584991
MolPort-003-848-373
NCGC00016973-01
NCGC00016973-02
NSC719345
Novartis Brand of Letrozole
Prestwick0_001025
Prestwick1_001025
Prestwick2_001025
Prestwick3_001025
S1235_Selleck
SAM001246649
SMR000466343
SPBio_003070
TL8000371
UNII-7LKK855W8I
ZINC03778874
letrozole
5
Progesteroneapproved, vet_approvedPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 153757-83-05994
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17a-Progesterone
17alpha-Progesterone
17alpha-progesterone
17α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
46665_FLUKA
46665_RIEDEL
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC-700
AC1L1LKF
AI3-51682
Agolutin
Akrolutin
BB_NC-0185
BHR-100
BIDD:ER0547
BIDD:PXR0094
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
Bio-luton
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
CPD000058345
Colprosterone
Corlutin
Corlutina
Corluvite
Corporin
Corpus Luteum Hormone
Corpus luteum hormone
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
D00066
D4-Pregnene-3,20-dione
DB00396
DR-2011
Delalutin
Delta(4)-pregnene-3,20-dione
Duraprogen
EINECS 200-350-6
ETI-411
EU-0100895
Endometrin
Estima
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
HSDB 3389
Hormoflaveine
Hormoluton
Hydroxyprogesterone Caproate
Hydroxyprogesterone Caproic acid
LMST02030159
LS-234
Lingusorbs
Lipo-Lutin
Lipolutin
Lopac0_000895
Lucorteum
Lucorteum Sol
Lucorteum sol
Lugesteron
Luteal hormone
Luteinique
Luteocrin normale
Luteodyn
Luteogan
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin M
Lutocyclin
Lutocyclin M
 
Lutocyclin m
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MPA
Membrettes
Methylpregnone
Micronized Progesterone
MolPort-001-794-643
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
NCI60_042166
NSC 64377
NSC 9704
NSC-9704
NSC64377
NSC9704
Nalutron
Natural Progesterone
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
PROGESTERONE
Percutacrine
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Prestwick_411
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, water-soluble
Progesterone-Water Soluble
Progesterone: HBC complex
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Progestérone
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
SR-01000000088
SR-01000000088-5
Spectrum5_002053
Syngesterone
Syngestrets
Synovex S
Syntolutan
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
beta-Progesterone
bmse000482
component of Cyclogesterin
corpus luteum hormone
delta(4)-Pregnene-3,20-dione
delta(Sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta4-Pregnene-3,20-dione
luteohormone
nchembio.2007.53-comp14
6
Ethinyl EstradiolapprovedPhase 4, Phase 271257-63-65991
Synonyms:
17 alpha-Ethinylestradiol
17 alpha-Ethynylestradiol
17 alpha-Ethynyloestradiol
17 alpha-ethinyestradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17-alpha-Ethinyl-17-beta-estradiol
17-alpha-Ethynyl-17-beta-oestradiol
17-alpha-Ethynylestradiol
17-alpha-Ethynylestradiol-17-beta
17-alpha-ethynyl estradiol
17-ethinyl-3,17-estradiol
17-ethinyl-3,17-oestradiol
17-ethinylestradiol
17.alpha.-Ethinyl-17.beta.-estradiol
17.alpha.-Ethinylestradiol
17.alpha.-Ethynyl-17.beta.-oestradiol
17.alpha.-Ethynylestradiol
17.alpha.-Ethynylestradiol-l7.beta.
17.alpha.-Ethynyloestradiol
17.alpha.-Ethynyloestradiol-17.beta.
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol
17a-Ethynylestradiol-l7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17alpha-Ethinylestradiol
17alpha-Ethinylestradiol-17beta
17alpha-Ethynylestradiol
17alpha-Ethynyloestradiol
17alpha-Ethynyloestradiol-17beta
17α-ethynylestradiol
406932-93-2
46263_FLUKA
46263_RIEDEL
57-63-6
77538-56-8
AC-2169
AC1L1LK6
AI3-52941
Aethinyloestradiolum
Aethinyoestradiol
Aethinyoestradiol [German]
Alora
Amenoron
Amenorone
Anovlar
BIDD:ER0162
BRN 2419975
Bio-0610
C07534
CCRIS 286
CHEBI:4903
CHEMBL691
CID5991
CPD000058319
Certostat
Chee-O-Gen
Chee-O-Genf
Cyclosa
D004997
D00554
DB00977
Dicromil
Diognat-E
Diogyn E
Diogyn-E
Diprol
Dyloform
E4876_SIGMA
EE
EE(sub 2)
EE2
EINECS 200-342-2
EO
ETHINYLESTRADIOL
Effik Brand of Ethinyl Estradiol
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Estinyl (TN)
Eston-E
Estopherol
Estoral
Estoral (Orion)
Estoral (VAN)
Estoral [Orion]
Estoral {[Orion]}
Estorals
Estradiol, Ethinyl
Estradiol, Ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl E2
Ethinyl Estradiol Hemihydrate
Ethinyl Estradiol [USP]
 
Ethinyl Estradiol, (8 alpha)-Isomer
Ethinyl Oestradiol Effik
Ethinyl estradiol
Ethinyl estradiol (USP)
Ethinyl-Oestradiol Effik
Ethinyl-Oestranol
Ethinyl-oestranol
Ethinylestradiol
Ethinylestradiol (JP15/INN)
Ethinylestradiol Jenapharm
Ethinylestradiol [INN:BAN:JAN]
Ethinylestradiolum
Ethinylestradiolum [INN-Latin]
Ethinylestriol
Ethinyloestradiol
Ethinyloestradiol [Steroidal oestrogens]
Ethy 11
Ethynyl estradiol
Ethynylestradiol
Ethynylestradiol, Ethinyl Estradiol
Ethynyloestradiol
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
Etinilestradiol
Etinilestradiol [INN-Spanish]
Etinilestradiolo
Etinilestradiolo [DCIT]
Etinoestryl
Etistradiol
Etivex
Evra
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
HMS2051I19
HSDB 3587
Halodrin
Hemihydrate, Ethinyl Estradiol
Inestra
Innofem
Jenapharm Brand of Ethinyl Estradiol
Jenapharm, Ethinylestradiol
Kolpolyn
LMST02010036
LS-231
Linoral
Lynoral
MLS000028479
MLS000758274
Marvelon
Menolyn
Menostar
Mercilon
Microfollin
Microfollin Forte
MolPort-001-794-636
NCGC00091533-01
NCGC00091533-04
NCGC00091533-05
NCI60_000234
NSC-10973
NSC10973
Neo-Estrone
Nogest-S
Novestrol
OVULEN-21
OVULEN-28
Oradiol
Orestralyn
Orestrayln
Organon Brand of Ethinyl Estradiol
Ortho-Cyclen
Ovex
Oviol
PUBERTAL ETHINYL ESTRADIOL STUDY
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn M
Progynon C
Progynon M
Prosexol
S1625_Selleck
SAM001247008
SGCUT00127
SMR000058319
Schering Brand of Ethinyl Estradiol
Spanestrin
Thiuram E
Thiuranide
UNII-423D2T571U
Vagifem
Varnoline
WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ
Ylestrol
component of Demulen
component of Oracon
component of Ortrel
ethinyl estradiol
ethynyl estradiol
to_000048
7
NorethindroneapprovedPhase 4, Phase 29368-22-46230
Synonyms:
(17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one
(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
17-Ethinyl-19-nor-testosterone
17-Ethinyl-19-nortestosterone
17-Ethynyl-17-hydroxyestr-4-en-3-one
17-Ethynyl-17-hydroxyestr-4-en-3-one (ACD/Name 4.0)
17-Ethynyl-17beta-hydroxyestr-4-en-3-one
17-Ethynyl-19-Nortestosterone
17-Hydroxy-(17alpha)-19-Norpregn-4-en-20-yn-3-one
17-Hydroxy-17-alpha-19-Norpregn-4-en-20-yn-3-one
17-Hydroxy-17-alpha-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-19-Nor-17alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one
17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one
17-alpha-Ethynyl-17-hydroxy-4-estren-3-one
17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one
17-alpha-Ethynyl-19-nortestosterone
17-alpha-Ethynyl-4-estren-17-ol-3-one
17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-ethynyl-17beta-hydroxyestr-4-en-3-one
17.alpha.-Ethinyl-19-nortestosterone
17.alpha.-Ethynyl-19-nortestosterone
17.alpha.-Ethynyl-4-estren-17-ol-3-one
17alpha-Ethinyl-17alpha-Ethinyl-19-nortestosterone
17alpha-Ethinyl-19-Nortestosterone
17alpha-Ethinyl-19-nortestosterone
17alpha-Ethinylestra-4-en-17beta-ol-3-one
17alpha-Ethynyl-17-hydroxy-4-estren-3-one
17alpha-Ethynyl-17-hydroxyest-4-en-3-one
17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one
17alpha-Ethynyl-17beta-hydroxyestr-4-en-3-one
17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one
17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one
17alpha-Ethynyl-19-nortestosterone
17alpha-Ethynyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-4-estren-17-ol-3-one
17alpha-ethynyl-17-hydroxy-Estr-4-en-3-one
17alpha-ethynyl-17beta-hydroxy-19-Norandrost-4-en-3-one
17alpha-pregn-4-en-20-yn-3-one
17beta-Hydroxy-17alpha-ethynylestr-4-en-3-one
17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17α-ethinyl-19-nortestosterone
19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one
19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one
19-Nor-17-alpha-ethynyltestosterone
19-Nor-17-ethinyl testosterone
19-Nor-17-ethinyltestosterone
19-Nor-17.alpha.-ethynyltestosterone
19-Nor-17alpa-ethynyltestosterone
19-Nor-17alpha-Ethynyl-17beta-hydroxy-4-androsten-3-one
19-Nor-17alpha-Ethynylandrosten-17beta-ol-3-one
19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one
19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one
19-Nor-17alpha-ethynyltestosterone
19-Nor-ethindrone
19-Nor-ethinyl--4,5-testosterone
19-Norethindrone
19-Norethinyltestosterone
19-Norethisterone
19-nor-17α-ethynyltestosterone
4-Estren-17alpha-ethynyl-17beta-ol-3-one
46525_FLUKA
46525_RIEDEL
68-22-4
A3564/0151191
AC-11100
AC1L1IDS
AC1L1M2R
AC1NWAOX
AC1O5EOU
AC1Q6OG5
AI3-26422
AKOS004119895
AR-1C1071
ARONIS24281
Activella
Anhydrohydroxynorprogesterone
Anovulatorio
Anovule
BB_NC-0600
BPBio1_000074
BRD-A39415247-001-02-1
BRD-K92073408-001-03-3
BRN 1915671
BSPBio_000066
BSPBio_002101
Brevicon
Brevinor
Brevinor 21
Brevinor 28
Brevinor-1 21
Brevinor-1 28
C05028
CCRIS 484
CHEBI:7627
CHEMBL1162
CID4536
CID5702093
CID6230
CID6432649
CPD000499579
Camila
Camila (TN)
Ciclovulan
Conceplan
Conludaf
Conludag
D00182
DB00717
Demulen
DivK1c_000553
EINECS 200-681-6
ENT
Errin
Estrinor
Ethinyl-19-nortestosterone
Ethinylnortestosterone
Ethynylmortestosterone
Ethynylnortestosterone
Gencept
Genora
Gestest
HMS1568D08
HMS1920B10
HMS2090D21
HMS2091J10
HMS501L15
HSDB 3370
I06-0104
 
IDI1_000553
Jenest
Jenest-28
KBio1_000553
KBio2_001491
KBio2_004059
KBio2_006627
KBio3_001601
KBioGR_000637
KBioSS_001491
LMST02030097
LS-97425
Loestrin
MLS001076679
MLS001163874
MLS001304093
Menzol
Microneth
Micronett
Micronor
Micronor (TN)
Micronovum
Milli
Mini-Pe
Mini-pill
Minovlar
MolPort-002-507-131
MolPort-002-509-542
MolPort-002-728-977
MolPort-003-861-444
N.E.E
N.E.E.
N0449
N4128_SIGMA
NCGC00178820-01
NCGC00179669-01
NET
NINDS_000553
NSC-9564
NSC9564
Nelova
Nodiol
Nor-Q.D
Nor-Q.D.
Nor-QD
Nora-BE
Noraethisteronum
Noralutin
Norcept
Norcept-E
Norcolut
Norcolute
Noresthisterone
Norethadrone
Norethin
Norethin 1/35 E
Norethin 1/50 M
Norethindirone
Norethindrone
Norethindrone (USP)
Norethindrone Norethisterone
Norethindrone [USAN]
Norethisteron
Norethisterone
Norethisterone (JP15)
Norethisterone [Progestins]
Norethisteronum
Norethisteronum [INN-Latin]
Norethyndron
Norethynodron
Norethynodrone
Noretisterona
Noretisterona [INN-Spanish]
Noretisterone
Noretisterone [DCIT]
Norfor
Norgestin
Noriday
Noriday 28
Norlutate
Norluten
Norlutin
Norluton
Normapause
Norpregneninlone
Norpregneninolone
Norpregneninotone
Oprea1_606355
Orlest
Ortho 1 35
Ortho 7 7 7
Ortho-Novum 1 35
Ortho-Novum 1 50
Ortho-Novum 7 7 7
Ovysmen 0.5 35
Ovysmen 1 35
Prestwick0_000253
Prestwick1_000253
Prestwick2_000253
Prestwick3_000253
Prestwick_646
Primolut N
Primolut-N
Primolut-N (TN)
Proluteasi
SAM002564223
SC 4640
SMR000499579
SMR000718762
SPBio_001052
SPBio_002285
SPECTRUM1500437
ST094767
STK730956
STOCK1N-04274
Spectrum2_001066
Spectrum3_000521
Spectrum4_000079
Spectrum5_001198
Spectrum_001011
Synphase
Synphasic 28
Tri-Norinyl
Triella
Trinovum 21
UNII-T18F433X4S
Utovlan
Utovlar
WLN: L E5 B666 OV MUTJ E FQ F1UU1 -A&F
ZINC03814419
component of Noriday
norethindrone
8
Megestrol acetateapproved, vet_approvedPhase 4, Phase 3, Phase 1, Phase 267595-33-511683
Synonyms:
17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione
17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate
17alpha-Acetoxy-6-dehydro-6-methylprogesterone
17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate
17α-Acetoxy-6-dehydro-6-methylprogesterone
17α-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate
6-Dehydro-6-methyl-17alpha-acetoxyprogesterone
6-Dehydro-6-methyl-17α-acetoxyprogesterone
6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione
 
6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate
6-Methyl-17α-acetoxypregna-4,6-diene-3,20-dione
6-Methyl-17α-hydroxy-delta(sup 6)-progesterone acetate
6-Methyl-6-dehydro-17alpha-acetoxyprogesterone
6-Methyl-6-dehydro-17α-acetoxyprogesterone
6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate
6-Methyl-delta(sup 4,6)-pregnadien-17α-ol-3,20-dione acetate
6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone
6-Methyl-delta(sup 6)-dehydro-17α-acetoxyprogesterone
MGA
Megace
9
BenzocaineapprovedPhase 4, Phase 218921994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
10
HydroxocobalaminapprovedPhase 424813422-51-011953898, 5460373, 44475014
Synonyms:
13422-51-0
22465-48-1
78091-12-0
8017-22-9
Acti-B12
AlphaRedisol
AlphaRedisol (TN)
Axion
Axlon
Benzimidazolyl ribofuranosyl phosphate deriv.
C08230
C62H85CoN13O15P
CHEBI:27786
CHEMBL1200742
CHEMBL235822
CID11622291
CID11953898
CID5460373
CID6433575
CID6474319
Ciplamin H
Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-Cobeta-hydroxocobamide
Cobalex
Cobalin H
Cobinamide dihydroxide dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole inner salt
Cobinamide, Co-hydroxy-, dihydrogen phosphate (ester), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, Co-hydroxy-, f-(dihydrogen phosphate), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono (inner salt), 3'- ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Cobinamide, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Codroxomin
Cyanokit
Cyanokit (TN)
D01027
DB00200
Depogamma
Docclan
Docelan
Docelvita
Docevita
Droxomin
Ducobee Hy
Ducobee-Hy
Duradoce
Duralta-12
EINECS 236-533-2
HSDB 3342
HYDROXOCOBALAMIN
Hidroxocobalamina
Hidroxocobalamina [INN-Spanish]
Hydro Cobex
 
Hydrobamine
Hydrocobalamin
Hydrogrisevit
Hydrovit
Hydroxocobalamin
Hydroxocobalamin (JAN/USP/INN)
Hydroxocobalamin Vitamin B12
Hydroxocobalamin [USAN:INN:BAN:JAN]
Hydroxocobalamin acetate
Hydroxocobalamin anhydrous
Hydroxocobalamin monohydrochloride
Hydroxocobalamin(alkaline soln.), OH- replaces CN- in Cyanocobalamin)
Hydroxocobalaminacetat
Hydroxocobalamine
Hydroxocobalamine [INN-French]
Hydroxocobalaminum
Hydroxocobalaminum [INN-Latin]
Hydroxocobalaminum anhydrous
Hydroxocobemine
Hydroxomin
Hydroxy Cobal
Hydroxy vitamin B12
Hydroxycob(lll)alamin
Hydroxycobalamin
Hydroxycobalamine
Hyxobamine
Idrogrisevit
Idrossocobalamina
Idrossocobalamina [DCIT]
LS-54607
Lyovit-H
Neo-Betalin 12
Neo-cytamen
Neo-macrabin
Neo-rojamin
OH-Cbl
OH-Duphar
Ohb12
Oxobemin
Oxolamine (arcum)
Primabalt RP
Redisol-H
S1668_Selleck
Sytobex-H
UNII-Q40X8H422O
Vibeden
Vitadurin
Vitamin B(sub 12a)
Vitamin B-12b
Vitamin B12a
Vitamin B12b
a-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
alpha Cobione
alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
vitamin B-12b
11
MetforminapprovedPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11746657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
12
TamoxifenapprovedPhase 4, Phase 3, Phase 2, Phase 138010540-29-12733526
Synonyms:
(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene
(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine
(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC)
(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE
(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
,citrate
1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
10540-29-1
1ya4
2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine
54965-24-1 (citrate)
AC1MBZ3R
Apo-Tamox
Apo-tamox
BIDD:ER0008
BIDD:GT0009
BIDD:PXR0003
BPBio1_000278
BRD-K93754473-001-02-9
BRD-K93754473-048-05-3
BSPBio_000252
BSPBio_001150
BSPBio_001982
C07108
C26H29NO
CCRIS 3275
CHEBI:41774
CHEMBL83
CID2733526
Citofen
Crisafeno
D08559
DB00675
Diemon
EINECS 234-118-0
Gen-Tamoxifen
Gen-tamoxifen
HMS1362J11
HMS1792J11
HMS1990J11
HMS2090N08
HSDB 6782
ICI 47699
ICI-46,474
ICI-47699
IDI1_000258
IDI1_002170
Istubol
Kessar
L024126
LS-393
Lopac0_001203
MLS001332535
MLS001332536
MolPort-003-850-384
 
NCGC00024928-01
NCGC00024928-03
NCGC00024928-04
NCGC00024928-05
NCGC00024928-07
NCGC00024928-08
NCGC00024928-09
NCGC00024928-12
NSC727681
Noltam
Nolvadex
Nolvadex-D
Nourytam
Novaldex
Novo-Tamoxifen
Oncomox
PMS-Tamoxifen
Pms-Tamoxifen
Prestwick2_000146
Prestwick3_000146
QTL1_000079
Retaxim
SMR000059172
ST50511785
Spectrum5_001417
Spectrum5_002043
T5648_SIGMA
TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1))
TRANS FORM OF TAMOXIFEN
Tamizam
Tamofen
Tamone
Tamoplex (TN)
Tamoxasta
Tamoxen
Tamoxifen
Tamoxifen (INN)
Tamoxifen (TN)
Tamoxifen (Z)
Tamoxifen Citrate
Tamoxifen [INN:BAN]
Tamoxifen and its salts
Tamoxifene
Tamoxifene [INN-French]
Tamoxifeno
Tamoxifeno [INN-Spanish]
Tamoxifenum
Tamoxifenum [INN-Latin]
Tamoxifène
Tocris-0999
Tomaxithen
Trans-Tamoxifen
UNII-094ZI81Y45
UPCMLD-DP027
Valodex
Zemide
cMAP_000044
nchembio.140-comp7
nchembio.76-comp1
nchembio732-comp3
tamoxifen
trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
trans-Tamoxifen
13
Cyproterone Acetateapproved, investigationalPhase 441427-51-0
Synonyms:
 
Cyproterone 17-O-acetate
14
Prednisoloneapproved, vet_approvedPhase 4115350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
15
Toremifeneapproved, investigationalPhase 42689778-26-73005573
Synonyms:
(Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)-N,N-dimethyl-ethylamine citrate(1:1)
2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine (IUPAC)
2-({4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenyl}oxy)-N,N-dimethylethanamine
2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine
89778-26-7
89778-27-8 (citrate (1:1))
98644-21-4
AC-1751
AC1MHJ33
Acapodene
BIDD:ER0222
BIDD:GT0211
BIDD:PXR0202
C08166
CCRIS 8745
CHEBI:9635
CHEMBL1655
CID3005573
D08620
DB00539
 
Estrimex
FC-1157a
Farestone
GTX-006 (Acapodene)
GTx 006
GTx-006
HMS2090B22
LS-7729
MolPort-002-508-208
NCGC00160530-01
STK626445
STOCK6S-27411
Toremifene (INN)
Toremifene Base
Toremifene Citrate (1:1)
Toremifene [INN:BAN]
Toremifeno
Toremifeno [Spanish]
Toremifenum
Toremifenum [Latin]
UNII-7NFE54O27T
Z-Toremifene
toremifene
{2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine
16
Methylprednisoloneapproved, vet_approvedPhase 4115383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
17
Leuprolideapproved, investigationalPhase 429353714-56-03911, 657181
Synonyms:
(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone
5-oxoPro-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-ProNHC2H5 dihydrate
5-oxoprolylhistidyltryptophylseryltyrosylleucylleucyl-n5-(diaminomethylidene)ornithyl-n-ethylprolinamide
AC1L1GZK
AC1L9B44
AC1Q5OPO
AR-1G9354
C07612
CID3911
CID441410
D00989
D08113
Enantone
Enantone (TN)
I04-0109
L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide
L001094
 
L002030
Leuprolide
Leuprolide acetate
Leuprolide acetate (USAN)
Leuprorelin
Leuprorelin (INN)
Leuprorelin acetate (JAN)
Leuprorelina
Leuproreline
Leuprorelinum
Lupron (TN)
N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
NSC377526
NSC746847
PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5
PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet
acetic acid
leuprolide
18DienogestapprovedPhase 44065928-58-7
19
Nandroloneapproved, illicitPhase 431434-22-09904, 229455
Synonyms:
(17-beta)-17-Hydroxyestr-4-en-3-one
(17beta)-17-hydroxyestr-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
17-Hydroxy-Estr-4-Ene-3-One
17-beta-Hydroestr-4-en-3-one
17beta-Hydroxy-19-nor-4-androsten-3-one
17beta-Hydroxy-19-norandrost-4-en-3-one
17beta-Hydroxy-4-estren-3-one
17beta-hydroxyestr-4-en-3-one
19-Norandrostenolone
19-Nortestosterone
19NTPP
4-Estren-17beta-ol-3-one
434-22-0
46476_FLUKA
46476_RIEDEL
74640_ALDRICH
74640_FLUKA
AC-15207
AC1L1U32
C07254
C18H26O2
CHEBI:7466
CHEMBL757
CID9904
CPD000058610
D08250
Deca-Durabolin
Durabolin
EINECS 207-101-0
Estr-4-en-3-one, 17-hydroxy-, (17-beta)- (9CI)
Estr-4-en-3-one, 17-hydroxy-, (17beta)- (9CI)
Estr-4-en-3-one, 17beta-hydroxy- (8CI)
Estrenolone
HMS2051I04
HSDB 3368
LMST02010044
LS-64851
LT03330030
MLS002222325
 
Menidrabol
MolPort-003-849-312
N7252_SIGMA
NCGC00159416-02
NPP
NSC 3351
NTPP
Nadrolone
Nadrolone phenylpropionate
Nandrolin
Nandrolon
Nandrolon phenylpropionate
Nandrolona
Nandrolona [INN-Spanish]
Nandrolone (INN)
Nandrolone Base
Nandrolone Decanoate
Nandrolone Decanoic acid
Nandrolone Phenpropionate
Nandrolone phenpropionate
Nandrolone phenylpionate
Nandrolone phenylpropionate
Nandrolonum
Nandrolonum [INN-Latin]
Norandrolone phenyl propionate
Norandrostenolon
Norandrostenolone
Norandrostenolone phenylpropionate
Nortestonate
Nortestosterone
Nortestosterone phenylpropionate
Nortestosteronum
Oestrenolon
SAM001246751
SMR000058610
Testosterone phenylpropionate
U 2410
UNII-6PG9VR430D
ZINC03814379
decadura
decadura (TN)
nandrolone
20
Nandrolone decanoateapproved, illicitPhase 431360-70-39677
Synonyms:
19-nortestosterone decanoate
Deca-durabolin
 
Nandrolone 17β-decanoate
Norandrostenolone decanoate
Nortestosterone decanoate
21
Folic Acidapproved, nutraceutical, vet_approvedPhase 4, Phase 3, Phase 2, Phase 1427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
22
Cyanocobalaminapproved, nutraceuticalPhase 424968-19-944176380
Synonyms:
Anacobin
Bedoz
Berocca PN
Berubigen
Betalin 12
Betalin 12 Crystalline
Betaline-12
Betolvex
Bevidox
Bevidox concentrate
Biocobalamine
Byladoce
Cabadon m
Cernevit-12
Cobadoce forte
Cobalin
Cobavite
Cobex
Cobolin-M
Copharvit 5000
Covit
Crystamin
Crystamine
Crysti-12
Crystimin
Crystwel
Cyano-B12
Cyanobalamin concentrate
Cyanocob(III)alamin
Cyanocobalamin (JP15/USP)
Cyanocobalamin Co 57 Schilling Test Kit
Cyanocobalamine
Cyanocobalmin
Cyanoject
Cycobemin
Cycolamin
Cykobemin
Cykobeminet
Cyomin
Cyredin
Cytacon
Cytamen
Cytobion
Depinar
Dicopac
Dicopac Kit
Dimethylbenzimidazoylcobamide
Distivit
Docemine
Docibin
Docivit
Dodecabee
Dodecavite
Dodex
Duodecibin
Embiol
Emociclina
Eritrone
Erycytol
 
Erythrotin
Euhaemon
Extrinsic factor
Factor II
Fermin
Fresmin
Hemomin
Hepagon
Hepavis
Hepcovite
Hylugel plus
Infuvite Pediatric
Lactobacillus lactis dorner factor
M.V.I. Pediatric
Macrabin
Megabion
Megalovel
Milbedoce
Millevit
Nagravon
Nascobal
Nascobal (TN)
Neuroforte-R
Normocytin
Novidroxin
Pernaemon
Pernaevit
Pernipuron
Plecyamin
Poyamin
Primabalt
Rebramin
Redamina
Redisol
Rhodacryst
Rubesol
Rubivite
Rubramin
Rubramin PC
Rubratope-57 Kit
Rubratope-60 Kit
Rubripca
Rubrocitol
Ruvite
Shovite
Sytobex
Vi-Twel
Vibal
Vibalt
Vibisone
Virubra
Vita-rubra
Vitabee 12
Vitamin B12
Vitamin B12 Preparation
Vitamin B12 complex
Vitaped
Vitarubin
Vitral
vitamine b12
23
Melatoninapproved, nutraceutical, vet_approvedPhase 425573-31-4896
Synonyms:
0E2B08C1-B325-45B1-8939-6F9081EFDFA4
4-ACETAMIDO-4'-ISOTHIO-CYANATOSTILBENE-2,2'-DISULFONIC ACID
5-22-12-00042 (Beilstein Handbook Reference)
5-Methoxy-N-acetyltryptamine
5-methoxy-N-acetyltryptamine
73-31-4
A4039/0172195
AB00053279
AC1L1A9Q
AC1Q4F1W
AC1Q4F1X
AKOS000276269
Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)- (9CI)
Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- (9CI)
Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]- (6CI,8CI)
Acetamide, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-}
Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-}
BAS 01281092
BIDD:ER0618
BPBio1_000590
BRD-K97530723-001-07-6
BRN 0205542
BSPBio_000536
BSPBio_003006
Bio-0635
C01598
CAS-73-31-4
CCRIS 3472
CHEBI:16796
CHEMBL45
CID896
ChemDiv2_003916
Circadin
D008550
D08170
DB01065
DB08189
DivK1c_000353
EINECS 200-797-7
EU-0100787
HMS1380B22
HMS1569K18
HMS1921E04
HMS2089F09
HMS501B15
HSCI1_000400
HSDB 7509
I05-0076
I10-0345
IDI1_000353
IDI1_002631
IN1244
KBio1_000353
KBio2_000665
KBio2_003233
KBio2_005801
KBio3_002226
KBioGR_000591
KBioSS_000665
L001261
LS-1623
Lopac-M-5250
Lopac0_000787
M 5250
M-1200
M-1250
M1105
M5250_SIGMA
ML1
MLS000859594
MLS001055382
MLS001240204
MT6
Mela-T
Melapure
Melatol
Melatonex
Melatonex, Melatonin
Melatonin
Melatonin (synth.) standard-grade
 
Melatonin (synth.) ultra-pure
Melatonina
Melatonina (TN)
Melatonine
Melovine
MolPort-000-737-883
N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)-Acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide
N-Acetyl-5-methoxy-tryptamine
N-Acetyl-5-methoxy-tryptamine Melatonine
N-Acetyl-5-methoxytryptamine
N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]-acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-Acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]-Acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]acetamide
N-[2-(5-methoxyindol-3-yl)ethyl]acetamide
N-acetyl-5-methoxy-tryptamine
NCGC00015680-01
NCGC00015680-02
NCGC00015680-03
NCGC00015680-06
NCGC00015680-13
NCGC00090727-01
NCGC00090727-02
NCGC00090727-03
NCGC00090727-04
NCGC00090727-05
NCGC00090727-06
NCGC00090727-07
NCGC00090727-08
NCGC00090727-09
NCI60_004378
NINDS_000353
NMR/14327425
NSC 113928
NSC113928
NSC56423
Nature'S Harmony
Night Rest
Oprea1_104553
Oprea1_814234
PREVENTION 1 (MELATONIN) (PREVENTION 1)
PREVENTION 2 (MELATONIN)
PREVENTION 3 (MELATONIN)
PREVENTION 4 (MELATONIN)
PREVENTION 5 (MELATONIN)
Pineal Hormone
Posidorm
Prestwick0_000458
Prestwick1_000458
Prestwick2_000458
Prestwick3_000458
Prestwick_312
Regulin
Revital Melatonin
Rx Balance
S1204_Selleck
SDCCGMLS-0065812.P001
SDCCGMLS-0065812.P002
SMP2_000309
SMR000326666
SPBio_001527
SPBio_002475
SPECTRUM1500690
STK386880
Sleep Right
Spectrum2_001344
Spectrum3_001393
Spectrum4_000066
Spectrum5_001745
Spectrum_000185
TNP00300
UNII-JL5DK93RCL
Vivitas
WLN: T56 BMJ D2MV1 GO1
ZINC00057060
{N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} Acetamide
{N-[2-(5-methoxyindol-3-yl)ethyl]-} Acetamide
24
Manganeseapproved, nutraceuticalPhase 4347439-96-527854
Synonyms:
 
Manganese
25tannic acidapproved, NutraceuticalPhase 4, Phase 21892
26
EnclomipheneinvestigationalPhase 4, Phase 2, Phase 3, Early Phase 116215690-57-0
Synonyms:
 
Clomiphene trans-form
27Estradiol valeratePhase 4, Phase 2, Phase 3, Early Phase 11283979-32-8
28Protective AgentsPhase 4, Phase 2, Phase 3, Phase 17190
29Contraceptives, OralPhase 4, Phase 3, Phase 2, Phase 11292
30Contraceptive Agents, MalePhase 4, Phase 3, Phase 2224
31
MedroxyprogesteronePhase 4, Phase 3, Phase 2145520-85-410631
Synonyms:
(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
(6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione
17 alpha Hydroxy 6 alpha Methylprogesterone
17 alpha-Hydroxy-6 alpha-Methylprogesterone
17-Hydroxy-6.alpha.-methylprogesterone
17-Hydroxy-6a-methylprogesterone
17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6alpha-methylprogesterone
17.alpha.-Hydroxy-6.alpha.-methylprogesterone
17alpha-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione
17alpha-Hydroxy-6alpha-methylprogesterone
4-08-00-02211 (Beilstein Handbook Reference)
46411_FLUKA
46411_RIEDEL
520-85-4
6-Dihydromegestrol
6-alpha-Methyl-17-alpha-hydroxyprogesterone
6.alpha.-Methyl-17.alpha.-hydroxyprogesterone
6alpha-Methyl-17alpha-hydroxyprogesterone
6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione
6alpha-Methyl-5-pregnen-17alpha-ol-3,20-dione
AC-14528
AC1L1VM7
Adgyn Medro
Aragest
Aragest 5
Asconale
BRN 2510965
C07119
CBP-1011
CHEBI:6715
CHEMBL1390
CID10631
CPD000058769
Clinofem
Clinovir
Colirest
Cycrin
D008525
D08166
DB00603
DMPA
Depo-Clinovir
Depo-Prodasone
Depo-Progestin
Depo-Promone
Depo-Provera
Depo-Subq Provera 104
Depot-Medroxyprogesterone acetate
EINECS 208-298-6
Farlutal
Farlutal inyectable
Farlutal inyectable (TN)
Farlutin
G-Farlutal
Gestapuran
HMS2052A13
HSDB 3114
Hematrol
Hydroxymethylprogesterone
Hysron
 
Indivina
LMST02030176
LS-118713
Lunelle
Lutopolar
Lutoral
M6013_SIGMA
MAP
MLS000069571
MLS001076098
MPA Gyn 5
Med-Pro
Medroprogesterone Acetate
Medrossiprogesterone
Medrossiprogesterone [DCIT]
Medrossiprogesterone [Dcit]
Medroxiprogesterona
Medroxiprogesterona [INN-Spanish]
Medroxiprogesteronum
Medroxyprogesteron
Medroxyprogesteron acetate
Medroxyprogesterone (INN)
Medroxyprogesterone Acetate
Medroxyprogesterone Strakan Brand
Medroxyprogesterone [INN:BAN]
Medroxyprogesteronum
Medroxyprogesteronum [INN-Latin]
Meprate
Methylhydroxyprogesterone
Metigestrona
MolPort-005-934-866
NCGC00023064-04
NSC 27408
NSC27408
Nadigest
Nidaxin
Novo-Medrone
Oragest
Perlutex
Perlutex Leo
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6-alpha)- (9CI)
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)- (9CI)
Prodasone
Progestalfa
Progevera
Provera
Proverone
Ralovera
Repromap
Repromix
SAM001246906
SMR000058769
ST082267
Sirprogen
Sodelut G
Strakan Brand of Medroxyprogesterone
U 8840
UNII-HSU1C9YRES
Veramix
ZINC05763835
g-Farlutal
medroxyprogesterone
32Steroid Synthesis InhibitorsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11718
33Appetite StimulantsPhase 4, Phase 3, Phase 1, Phase 264
34Vitamin B ComplexPhase 4, Phase 3, Phase 2, Phase 14229
35EstrogensPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 12470
36Chorionic GonadotropinPhase 4, Phase 3, Phase 2188
37Contraceptive AgentsPhase 4, Phase 3, Phase 2, Phase 11901
38HormonesPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 113979
39Insulin, Globin ZincPhase 4, Phase 24523
40insulinPhase 4, Phase 24524
41Contraceptives, Oral, CombinedPhase 4, Phase 3625
42Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 112767
43Aromatase InhibitorsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 1807
44Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 112778
45Polyestradiol phosphatePhase 4, Phase 2, Phase 3, Early Phase 11283
46Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 15407
47ZuclomiphenePhase 4, Phase 2, Phase 3, Early Phase 1162
48AnticoagulantsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 12516
49Calcium, DietaryPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 15525
50Chelating AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 11365

Interventional clinical trials:

(show top 50)    (show all 815)
idNameStatusNCT IDPhase
1Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic SurgeryUnknown statusNCT00719017Phase 4
2Influence of Gum Chewing on Postoperative Bowel Activity After Complete Staging Surgery for Gynecological MalignanciesUnknown statusNCT01835119Phase 4
3A Study Comparing Mirena and Systemic Progestin for Endometrial HyperplasiaUnknown statusNCT01074892Phase 4
4Endometrial Scratching During Laproscopic Ovarian Drilling in Subfertile PCOS WomenUnknown statusNCT02140398Phase 4
5A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue TreatmentCompletedNCT00190697Phase 4
6Apoptotic Signaling Pathways in Rats With Endometrial HyperplasiaCompletedNCT02872818Phase 4
7Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian FailureCompletedNCT00732693Phase 4
8Exercise and Phytoestrogens: Effect on Factors Predisposing to Cardiovascular Disease(CVD) in Postmenopausal WomenCompletedNCT01048606Phase 4
9Effect of Hormone Replacement Therapy on Lupus ActivityCompletedNCT00392093Phase 4
10The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine InseminationCompletedNCT01219101Phase 4
11Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOSCompletedNCT02352597Phase 4
12Letrozole Versus Clomifene Citrate for Ovulation InductionCompletedNCT00478504Phase 4
13Role of Melatonin Supplementation in Follicular Fluid of in Vitro Fertilization (IVF) Patients With Polycystic Ovarian SyndromeCompletedNCT01540747Phase 4
14Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound ParametersCompletedNCT01514942Phase 4
15Biomarker Guided Treatment in Gynaecological CancerRecruitingNCT02543710Phase 4
16Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast CancerRecruitingNCT02344940Phase 4
17HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS PatientsRecruitingNCT02273791Phase 4
18Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine LeiomyomaRecruitingNCT02361879Phase 4
19Adding Prednisolone During Ovulation Induction With CC in Lean Women With CC Resistant PCOSRecruitingNCT02344888Phase 4
20Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOSRecruitingNCT02436226Phase 4
21The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOSRecruitingNCT02866786Phase 4
22Endometrial Preparation Before Operative Hysteroscopy in Premenopausal WomenNot yet recruitingNCT02440750Phase 4
23IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF FailureNot yet recruitingNCT02601196Phase 4
24Pharmacokinetics and Safety of Transdermal Megestrol AcetateWithdrawnNCT00163072Phase 4
25Effect of Progestin-Induced Withdrawal Bleed on Ovulation Induction Cycles With Clomiphene CitrateWithdrawnNCT01966575Phase 4
26The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial CarcinomaUnknown statusNCT01820858Phase 3
27The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological MalignanciesUnknown statusNCT00726635Phase 3
28Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic CancerUnknown statusNCT01087268Phase 3
29Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity CancerUnknown statusNCT00954174Phase 3
30Single-port Access Laparoscopic-assisted Vaginal HysterectomyUnknown statusNCT01048931Phase 3
31Effects of the Concentrated Extract of Soy on Coagulation Factors After MenopauseUnknown statusNCT00925639Phase 3
32Study to Prevent Radiation Induced Damage to Bowel Using a Prebiotic Enhanced Diet.Unknown statusNCT01414517Phase 3
33Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00262847Phase 3
34Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00006011Phase 3
35Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial CancerCompletedNCT00002568Phase 3
36Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian CancerCompletedNCT00003322Phase 3
37Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00002717Phase 3
38Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian CancerCompletedNCT00003644Phase 3
39Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00483782Phase 3
40An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationCompletedNCT00132704Phase 3
41Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial CancerCompletedNCT00006027Phase 3
42Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial CancerCompletedNCT00002493Phase 3
43Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT00003691Phase 3
44External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial CancerCompletedNCT00376844Phase 3
45Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial CancerCompletedNCT00003749Phase 3
46Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial CancerCompletedNCT00005583Phase 3
47Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone SurgeryCompletedNCT00002807Phase 3
48S9630, Medroxyprogesterone in Treating Women With Breast CancerCompletedNCT00002920Phase 3
49Tachosil for the Prevention of Symptomatic Lymph CystsCompletedNCT01470677Phase 3
50Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the UterusCompletedNCT00002459Phase 3

Search NIH Clinical Center for Endometrial Cancer

Inferred drug relations via UMLS67/NDF-RT45:


Cochrane evidence based reviews: carcinoma, endometrioid

Genetic Tests for Endometrial Cancer

About this section

Genetic tests related to Endometrial Cancer:

id Genetic test Affiliating Genes
1 Endometrial Carcinoma26
2 Endometrial Neoplasm26
3 Endometrial Carcinoma, Somatic24 MSH3

Anatomical Context for Endometrial Cancer

About this section

MalaCards organs/tissues related to Endometrial Cancer:

35
Uterus, Lymph node, Ovary, Testes, Endothelial, Colon, Cervix

FMA organs/tissues related to Endometrial Cancer:

17
The tissue lining the uterus

Animal Models for Endometrial Cancer or affiliated genes

About this section

MGI Mouse Phenotypes related to Endometrial Cancer:

40 (show all 33)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000537710.8CTNNB1, EGFR, ESR2, FGFR2, KRAS, TP53
2MP:000118610.7CTNNB1, EGFR, FGFR2, KRAS, PTEN, TP53
3MP:000537010.6CTNNB1, EGFR, ESR1, ESR2, FGFR2, KRAS
4MP:000537110.5CTNNB1, EGFR, ERBB2, ESR1, ESR2, FGFR2
5MP:000538010.5CDH1, CTNNB1, EGFR, ERBB2, ESR1, FGFR2
6MP:000538810.5CCND1, CTNNB1, EGFR, ERBB2, ESR1, ESR2
7MP:000301210.5CDH1, CTNNB1, EGFR, ESR1, ESR2, FGFR2
8MP:000538210.5CCND1, CTNNB1, EGFR, ERBB2, FGFR2, KRAS
9MP:000536910.5CTNNB1, EGFR, ERBB2, ESR1, ESR2, FGFR2
10MP:000539110.4CCND1, CTNNB1, EGF, EGFR, FGFR2, KRAS
11MP:000539010.4CCND1, CTNNB1, EGFR, ERBB2, ESR1, ESR2
12MP:000538910.3CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
13MP:000537910.3CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
14MP:000539710.3CCND1, CTNNB1, EGFR, ESR1, ESR2, FGFR2
15MP:000200610.3CCND1, CDH1, CTNNB1, EGFR, ERBB2, ESR1
16MP:000287310.2CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
17MP:000538410.2CCND1, CDH1, CTNNB1, EGFR, ERBB2, ESR1
18MP:000538710.2CCND1, CDH1, CTNNB1, EGF, EGFR, ESR1
19MP:000537510.2EGFR, ESR1, ESR2, FGFR2, PIK3CA, PTEN
20MP:000538610.2CCND1, CTNNB1, ERBB2, ESR1, ESR2, FGFR2
21MP:001077110.2CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
22MP:000363110.1CCND1, CTNNB1, EGFR, ERBB2, ESR1, ESR2
23MP:000537810.1CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
24MP:001076810.1CCND1, CDH1, CTNNB1, EGFR, ERBB2, ESR1
25MP:000538510.0CCND1, CDH1, CTNNB1, EGFR, ERBB2, ESR1
26MP:00053769.9CCND1, CDH1, CTNNB1, EGFR, ERBB2, ESR1
27MP:00053679.9CTNNB1, EGFR, ESR1, ESR2, FGFR2, KRAS
28MP:00053819.8CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2

Publications for Endometrial Cancer

About this section

Articles related to Endometrial Cancer:

(show top 50)    (show all 1407)
idTitleAuthorsYear
1
Minimally Invasive Approach in Type II endometrial cancer: it is wise and safe? (28065812)
2017
2
In reply to Binder et al "Adult Comorbidity Evaluation 27 Score in Endometrial Cancer Patient". (27640945)
2016
3
Co-expression of galectin-3 and CRIP-1 in endometrial cancer: prognostic value and patient survival. (26708131)
2016
4
POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer. (25878334)
2015
5
Association of the +331G/A progesterone receptor gene (PgR) polymorphism with risk of endometrial cancer in Caucasian women: a meta-analysis. (25037596)
2015
6
HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant. (25602714)
2015
7
CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer. (25281766)
2014
8
The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer. (24651628)
2014
9
Switch in FOXA1 status associates with endometrial cancer progression. (24849812)
2014
10
Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer. (25001096)
2014
11
Suppression of the epithelial-mesenchymal transition by SHARP1 is linked to the NOTCH1 signaling pathway in metastasis of endometrial cancer. (24997474)
2014
12
Relation of Preoperative Thrombocytosis between Tumor Stage and Grade in Patients with Endometrial Cancer. (25610319)
2014
13
Genome-wide association study of endometrial cancer in E2C2. (24096698)
2014
14
Methylation of the HOXA10 homeobox gene promoter is associated with endometrial cancer: a pilot study. (23815210)
2013
15
The effect of cadmium on the coagulation and fibrinolytic system in women with uterine endometrial cancer and myoma. (23690264)
2013
16
Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer. (22037318)
2012
17
GRP78 induced by estrogen plays a role in the chemosensitivity of endometrial cancer. (22543280)
2012
18
KCC1 gene advances cell invasion ability by regulating ERK signaling pathway in endometrial cancer HEC-1B cell line. (21666489)
2011
19
Testing women with endometrial cancer to detect Lynch syndrome. (21537049)
2011
20
Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer. (20082853)
2010
21
Double strand break repair components are frequent targets of microsatellite instability in endometrial cancer. (20638839)
2010
22
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer. (19396818)
2009
23
Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival. (19319135)
2009
24
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. (19124504)
2009
25
Selective gene transfer to endometrial cancer cells by a polymer against matrix metalloproteinase 2 (MMP-2). (18454694)
2008
26
A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer. (18348659)
2008
27
Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. (17285578)
2007
28
Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation]. (17697604)
2007
29
p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells. (17636407)
2007
30
The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer. (17167982)
2006
31
Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR. (16683245)
2006
32
Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines. (15866122)
2005
33
Estrogen receptor beta (ESR2 ) polymorphisms and endometrial cancer (United States). (15280642)
2004
34
Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. (15016316)
2004
35
Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells. (15458748)
2004
36
Arzoxifene as therapy for endometrial cancer. (12928005)
2003
37
Expression and potential roles of pregnane X receptor in endometrial cancer. (12970323)
2003
38
Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture. (12631221)
2003
39
Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia. (12111402)
2002
40
High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer. (11774293)
2002
41
Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance. (11263931)
2001
42
Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer. (11056312)
2000
43
Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer. (10831349)
2000
44
Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer. (11078809)
2000
45
Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. (11268488)
2000
46
Epidermal growth factor activates protein kinase C in the human endometrial cancer cell line HEC-1-A. (9345355)
1997
47
Multiple isoforms of the oestrogen receptor in endometrial cancer. (7669226)
1995
48
Expression of sex hormone-binding globulin mRNA in human endometrial cancers. (7779755)
1995
49
Expression of aberrant estrogen receptor mRNA in endometrial cancers in comparison with normal endometria. (7995615)
1994
50
Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer]. (8508979)
1993

Variations for Endometrial Cancer

About this section

UniProtKB/Swiss-Prot genetic disease variations for Endometrial Cancer:

69
id Symbol AA change Variation ID SNP ID
1PTENp.His123TyrVAR_026260rs786204931

Clinvar genetic disease variations for Endometrial Cancer:

5 (show all 12)
id Gene Variation Type Significance SNP ID Assembly Location
1CDH1NM_004360.4(CDH1): c.2131C> G (p.Leu711Val)SNVPathogenicrs121964871GRCh37Chr 16, 68857496: 68857496
2KRASNM_033360.3(KRAS): c.34G> T (p.Gly12Cys)SNVPathogenicrs121913530GRCh37Chr 12, 25398285: 25398285
3KRASNM_004985.4(KRAS): c.40G> A (p.Val14Ile)SNVPathogenicrs104894365GRCh37Chr 12, 25398279: 25398279
4FGFR2NM_022970.3(FGFR2): c.755C> G (p.Ser252Trp)SNVPathogenicrs79184941GRCh37Chr 10, 123279677: 123279677
5FGFR2NM_000141.4(FGFR2): c.1124A> G (p.Tyr375Cys)SNVPathogenicrs121913478GRCh37Chr 10, 123274794: 123274794
6MUTYHNM_001128425.1(MUTYH): c.536A> G (p.Tyr179Cys)SNVPathogenicrs34612342GRCh37Chr 1, 45798475: 45798475
7MUTYHNM_001128425.1(MUTYH): c.1187G> A (p.Gly396Asp)SNVPathogenicrs36053993GRCh37Chr 1, 45797228: 45797228
8MLH3NM_001040108.1(MLH3): c.2221G> T (p.Val741Phe)SNVPathogenicrs28756990GRCh37Chr 14, 75514138: 75514138
9MLH3MLH3, 1-BP DEL, 885GdeletionPathogenicChr na, -1: -1
10PTENNM_000314.6(PTEN): c.253+1G> ASNVPathogenicrs587776667GRCh37Chr 10, 89690847: 89690847
11MSH3NM_002439.4(MSH3): c.1148delA (p.Lys383Argfs)deletionPathogenicrs587776701GRCh38Chr 5, 80675103: 80675103
12MSH6NM_000179.2(MSH6): c.2731C> T (p.Arg911Ter)SNVPathogenicrs63751017GRCh37Chr 2, 48027853: 48027853

Cosmic variations for Endometrial Cancer:

8 (show top 50)    (show all 597)
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA Conf
1COSM5154PTENendometrium,NS,carcinoma,endometrioid carcinomac.697C>Tp.R233*12
2COSM754PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.1035T>Ap.N345K12
3COSM12597PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.3145G>Cp.G1049R12
4COSM5347125ARID1Aendometrium,NS,carcinoma,endometrioid carcinomac.3988C>Tp.Q1330*12
5COSM5285PTENendometrium,NS,carcinoma,endometrioid carcinomac.380G>Tp.G127V12
6COSM1041506PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.2173G>Ap.D725N12
7COSM5256PTENendometrium,NS,carcinoma,endometrioid carcinomac.76A>Cp.T26P12
8COSM5347001ARID1Aendometrium,NS,carcinoma,endometrioid carcinomac.2686G>Tp.E896*12
9COSM5662CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.110C>Tp.S37F12
10COSM5219PTENendometrium,NS,carcinoma,endometrioid carcinomac.388C>Gp.R130G12
11COSM521KRASendometrium,NS,carcinoma,endometrioid carcinomac.35G>Ap.G12D12
12COSM12590PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.3073A>Tp.T1025S12
13COSM5686CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.100G>Ap.G34R12
14COSM746PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.263G>Ap.R88Q12
15COSM27158PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.3146G>Cp.G1049A12
16COSM1044601CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.1657A>Gp.M553V12
17COSM51211PPP2R1Aendometrium,NS,carcinoma,endometrioid carcinomac.547C>Tp.R183W12
18COSM6144PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.3193C>Tp.H1065Y12
19COSM5677CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.98C>Gp.S33C12
20COSM36912FGFR2endometrium,NS,carcinoma,endometrioid carcinomac.1647T>Ap.N549K12
21COSM10654TP53endometrium,NS,carcinoma,endometrioid carcinomac.637C>Tp.R213*12
22COSM5663CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.133T>Cp.S45P12
23COSM517KRASendometrium,NS,carcinoma,endometrioid carcinomac.34G>Ap.G12S12
24COSM11582TP53endometrium,NS,carcinoma,endometrioid carcinomac.395A>Gp.K132R12
25COSM5667CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.134C>Tp.S45F12
26COSM5218PTENendometrium,NS,carcinoma,endometrioid carcinomac.509G>Tp.S170I12
27COSM554KRASendometrium,NS,carcinoma,endometrioid carcinomac.183A>Cp.Q61H12
28COSM972490CTCFendometrium,NS,carcinoma,endometrioid carcinomac.1342C>Tp.R448*12
29COSM5676CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.122C>Tp.T41I12
30COSM5347098ARID1Aendometrium,NS,carcinoma,endometrioid carcinomac.2581G>Ap.A861T12
31COSM5094PTENendometrium,NS,carcinoma,endometrioid carcinomac.59G>Ap.G20E12
32COSM5122PTENendometrium,NS,carcinoma,endometrioid carcinomac.424C>Tp.R142W12
33COSM5716CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.121A>Tp.T41S12
34COSM238574CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.65T>Gp.V22G12
35COSM520KRASendometrium,NS,carcinoma,endometrioid carcinomac.35G>Tp.G12V12
36COSM5032PTENendometrium,NS,carcinoma,endometrioid carcinomac.394G>Ap.G132S12
37COSM5152PTENendometrium,NS,carcinoma,endometrioid carcinomac.388C>Tp.R130*12
38COSM10704TP53endometrium,NS,carcinoma,endometrioid carcinomac.844C>Tp.R282W12
39COSM744PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.112C>Tp.R38C12
40COSM17448PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.3194A>Tp.H1065L12
41COSM12461PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.3062A>Gp.Y1021C12
42COSM28917PTENendometrium,NS,carcinoma,endometrioid carcinomac.386G>Ap.G129E12
43COSM5153PTENendometrium,NS,carcinoma,endometrioid carcinomac.49C>Tp.Q17*12
44COSM775PIK3CAendometrium,NS,carcinoma,endometrioid carcinomac.3140A>Gp.H1047R12
45COSM534555ARID1Aendometrium,NS,carcinoma,endometrioid carcinomac.1303C>Tp.Q435*12
46COSM13460PTENendometrium,NS,carcinoma,endometrioid carcinomac.462C>Ap.F154L12
47COSM5669CTNNB1endometrium,NS,carcinoma,endometrioid carcinomac.98C>Tp.S33F12
48COSM516KRASendometrium,NS,carcinoma,endometrioid carcinomac.34G>Tp.G12C12
49COSM3724474ARID1Aendometrium,NS,carcinoma,endometrioid carcinomac.6694C>Tp.R2232W12
50COSM5199PTENendometrium,NS,carcinoma,endometrioid carcinomac.334C>Gp.L112V12

Copy number variations for Endometrial Cancer from CNVD:

6 (show top 50)    (show all 66)
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1147991110230418110236367DuplicationGSTM1Endometrial cancer
2164301124300000247249719GainEndometrial cancer
3164311124300000247249719GainEndometrial cancer
4164431124300000247249719Gain or lossEndometrial cancer
53000512390000028000000Copy numberSTMN1Endometrial cancer
63817010140300000GainEndometrial cancer
73817310140300000Gain or lossEndometrial cancer
8428091040300000135374737GainEndometrial cancer
9428101040300000135374737Gain or lossEndometrial cancer
1047133108961317489718512Copy numberPTENEndometrial cancer
1147161108962319489728531LossPTENEndometrial cancer
124849511152900000Gain or lossEndometrial cancer
13554321152900000134452384Gain or lossEndometrial cancer
146153612135400000Gain or lossEndometrial cancer
1566123122535817925403863AmplificationKRASEndometrial cancer
16751501316000000114142980Gain or lossEndometrial cancer
17828141415600000106368585Gain or lossEndometrial cancer
18892411517000000100338915Gain or lossEndometrial cancer
199727416138200000GainEndometrial cancer
209727616138200000Gain or lossEndometrial cancer
21101463163820000088827254Gain or lossEndometrial cancer
2210679317122200000Gain or lossEndometrial cancer
23108760172220000078774742Gain or lossEndometrial cancer
2411917018116100000Gain or lossEndometrial cancer
25119734181610000076117153Gain or lossEndometrial cancer
2612409819128500000Gain or lossEndometrial cancer
27127175192850000063811651Gain or lossEndometrial cancer
281343552193300000Gain or lossEndometrial cancer
2914625624748376647760012RearrangementMSH2Endometrial cancer
30149784293300000242951149Gain or lossEndometrial cancer
3115041620127100000Gain or lossEndometrial cancer
32151944202710000062435964GainEndometrial cancer
33151953202710000062435964Gain or lossEndometrial cancer
34157114211230000046944323Gain or lossEndometrial cancer
35160291221180000049691432Gain or lossEndometrial cancer
36163141222437613924384284DuplicationGSTT1Endometrial cancer
371661553191700000Gain or lossEndometrial cancer
381720273175700000179000000AmplificationPIK3CAEndometrial cancer
3917501633700998237067341RearrangementMLH1Endometrial cancer
40179466391700000199501827Gain or lossEndometrial cancer
411799844150700000Gain or lossEndometrial cancer
42187532450700000191273063Gain or lossEndometrial cancer
43200012547700000180857866Gain or lossEndometrial cancer
442036996160500000Gain or lossEndometrial cancer
45214470660500000170899992Gain or lossEndometrial cancer
462171177159100000Gain or lossEndometrial cancer
47226563759100000158821424Gain or lossEndometrial cancer
482308338145200000Gain or lossEndometrial cancer
49240068845200000146274826GainEndometrial cancer
50240080845200000146274826Gain or lossEndometrial cancer

Expression for genes affiliated with Endometrial Cancer

About this section
Search GEO for disease gene expression data for Endometrial Cancer.

Pathways for genes affiliated with Endometrial Cancer

About this section

Pathways related to Endometrial Cancer according to GeneCards Suite gene sharing:

(show all 46)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
10.3MLH1, MLH3, MSH2, MSH3, MSH6
210.3EGF, EGFR, FGFR2, KRAS
310.3CDH1, CTNNB1, EGF, EGFR
410.3CCND1, CDH1, CTNNB1, PIK3CA
510.3EGF, EGFR, KRAS, PIK3CA
610.3CCND1, ESR1, ESR2, KRAS
710.3EGFR, MLH1, MSH2, PTEN, TP53
810.3CCND1, CDH1, CTNNB1, KRAS, TP53
910.3CDH1, EGF, EGFR, ERBB2, PIK3CA
1010.3CDH1, CTNNB1, EGFR, ERBB2, TGFBR2
1110.3EGF, EGFR, KRAS, PIK3CA, TP53
12
Show member pathways
10.3CCND1, EGF, EGFR, ERBB2, KRAS
13
Show member pathways
10.3CCND1, KRAS, MLH1, MSH2, PTEN, TP53
1410.3CCND1, CTNNB1, ESR1, TGFBR2, TP53
15
Show member pathways
10.3EGF, EGFR, ERBB2, KRAS, PIK3CA, PTEN
1610.2CCND1, CTNNB1, ESR1, KRAS, PIK3CA, TP53
1710.2EGFR, ERBB2, FGFR2, KRAS, PIK3CA, PTEN
18
Show member pathways
10.2CCND1, ERBB2, ESR1, ESR2, KRAS, PIK3CA
19
Show member pathways
10.2CCND1, EGFR, ERBB2, FGFR2, KRAS, PTEN
20
Show member pathways
10.2CCND1, ESR1, ESR2, MSH2, MSH3, MSH6
2110.2CCND1, CTNNB1, KRAS, PIK3CA, TGFBR2, TP53
22
Show member pathways
10.2CDH1, CTNNB1, EGF, EGFR, FGFR2, KRAS
2310.2CCND1, EGFR, ERBB2, KRAS, PIK3CA, PTEN
2410.2CCND1, CDH1, EGF, EGFR, ERBB2, KRAS
2510.2CCND1, CTNNB1, EGF, EGFR, KRAS, PTEN
26
Show member pathways
10.2CDH1, EGF, EGFR, FGFR2, KRAS, PIK3CA
27
Show member pathways
10.2CDH1, CTNNB1, ERBB2, ESR1, KRAS, PIK3CA
28
Show member pathways
10.2CCND1, EGF, EGFR, ERBB2, KRAS, PIK3CA
29
Show member pathways
10.2CCND1, EGF, EGFR, KRAS, PIK3CA, PTEN
30
Show member pathways
10.2CCND1, EGF, EGFR, ERBB2, ESR1, ESR2
3110.2CCND1, EGF, EGFR, FGFR2, KRAS, PIK3CA
32
Show member pathways
10.2CCND1, CTNNB1, EGF, EGFR, ERBB2, KRAS
33
Show member pathways
10.2CTNNB1, EGFR, ERBB2, FGFR2, KRAS, PIK3CA
34
Show member pathways
10.2CCND1, CTNNB1, EGFR, ESR1, ESR2, KRAS
3510.2CCND1, CTNNB1, EGFR, ERBB2, ESR1, KRAS
36
Show member pathways
10.2CCND1, CTNNB1, EGF, EGFR, ERBB2, PIK3CA
37
Show member pathways
10.2CDH1, CTNNB1, EGF, EGFR, ERBB2, ESR1
38
Show member pathways
10.2CCND1, EGF, EGFR, ERBB2, KRAS, PIK3CA
39
Show member pathways
10.1CTNNB1, EGF, EGFR, ERBB2, FGFR2, KRAS
4010.1CCND1, CDH1, CTNNB1, EGFR, ESR1, KRAS
41
Show member pathways
10.1CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
4210.1CCND1, CTNNB1, EGF, EGFR, ERBB2, ESR1
4310.1CCND1, CDH1, CTNNB1, EGF, EGFR, KRAS
44
Show member pathways
10.0CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
45
Show member pathways
10.0CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2
469.9CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2

GO Terms for genes affiliated with Endometrial Cancer

About this section

Cellular components related to Endometrial Cancer according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1MutSbeta complexGO:003230211.3MSH2, MSH3
2MutSalpha complexGO:003230111.3MSH2, MSH6
3chiasmaGO:000571211.2MLH1, MLH3
4flotillin complexGO:001660011.0CDH1, CTNNB1
5catenin complexGO:001634211.0CDH1, CTNNB1
6apical junction complexGO:004329611.0CDH1, CTNNB1
7receptor complexGO:004323510.9EGF, EGFR, ERBB2, TGFBR2
8perinuclear region of cytoplasmGO:004847110.6CDH1, CTNNB1, EGFR, ERBB2, ESR1, ESR2
9membraneGO:001602010.2CCND1, CTNNB1, EGFR, ESR1, FGFR2, KRAS
10nucleoplasmGO:000565410.1CCND1, CTNNB1, ESR1, ESR2, FGFR2, MLH1
11plasma membraneGO:00058869.7CDH1, CTNNB1, EGF, EGFR, ERBB2, ESR1

Biological processes related to Endometrial Cancer according to GeneCards Suite gene sharing:

(show all 50)
idNameGO IDScoreTop Affiliating Genes
1meiotic mismatch repairGO:000071011.2MSH2, MSH3, MSH6
2somatic recombination of immunoglobulin genes involved in immune responseGO:000220411.2MLH1, MSH2
3prostate epithelial cord arborization involved in prostate glandular acinus morphogenesisGO:006052711.1ESR1, FGFR2
4prostate epithelial cord elongationGO:006052311.1ESR1, FGFR2
5somatic hypermutation of immunoglobulin genesGO:001644611.1MLH1, MSH2, MSH6
6somatic recombination of immunoglobulin gene segmentsGO:001644711.1MLH1, MSH2, MSH6
7maintenance of DNA repeat elementsGO:004357011.1MSH2, MSH3, MSH6
8negative regulation of DNA recombinationGO:004591011.1MSH2, MSH3, MSH6
9determination of adult lifespanGO:000834011.1MSH2, MSH6, TP53
10mismatch repairGO:000629811.0MLH1, MLH3, MSH2, MSH3, MSH6
11response to UV-AGO:007014111.0CCND1, EGFR
12isotype switchingGO:004519011.0MLH1, MSH2, MSH6
13positive regulation of helicase activityGO:005109611.0MSH2, MSH3, MSH6
14response to X-rayGO:001016511.0CCND1, MSH2, TP53
15intrinsic apoptotic signaling pathway in response to DNA damageGO:000863011.0MLH1, MSH2, MSH6
16cellular response to indole-3-methanolGO:007168110.9CDH1, CTNNB1
17phosphatidylinositol phosphorylationGO:004685410.9EGF, EGFR, ERBB2, FGFR2, PIK3CA
18regulation of phosphatidylinositol 3-kinase signalingGO:001406610.9EGF, EGFR, ERBB2, FGFR2, PIK3CA
19mesenchymal cell proliferation involved in lung developmentGO:006091610.9CTNNB1, FGFR2
20trachea morphogenesisGO:006043910.9CTNNB1, TGFBR2
21positive regulation of mesenchymal cell proliferationGO:000205310.9CTNNB1, FGFR2, TGFBR2
22negative regulation of neuron deathGO:190121510.9CTNNB1, ESR1, ESR2
23cellular response to estradiol stimulusGO:007139210.9EGFR, ESR1, ESR2
24mammary gland alveolus developmentGO:006074910.9CCND1, EGF, ESR1
25positive regulation of protein phosphorylationGO:000193410.9CCND1, EGFR, ERBB2, KRAS
26phosphatidylinositol-mediated signalingGO:004801510.8EGF, EGFR, ERBB2, FGFR2, PIK3CA, PTEN
27peptidyl-tyrosine phosphorylationGO:001810810.8EGF, EGFR, ERBB2, FGFR2
28ERBB2 signaling pathwayGO:003812810.8EGF, EGFR, ERBB2, KRAS, PIK3CA
29positive regulation of sequence-specific DNA binding transcription factor activityGO:005109110.8CTNNB1, ESR1, ESR2, PTEN
30embryonic cranial skeleton morphogenesisGO:004870110.8CTNNB1, FGFR2, TGFBR2
31response to organic cyclic compoundGO:001407010.8CCND1, EGFR, PTEN, TGFBR2
32canonical Wnt signaling pathwayGO:006007010.8CCND1, CTNNB1, EGF, PTEN
33epidermal growth factor receptor signaling pathwayGO:000717310.8EGF, EGFR, KRAS, PIK3CA
34liver developmentGO:000188910.7CCND1, CTNNB1, EGFR, KRAS, PIK3CA
35response to estrogenGO:004362710.7CCND1, CTNNB1, ESR1, ESR2, TGFBR2
36positive regulation of epithelial cell proliferationGO:005067910.7EGFR, ERBB2, ESR1, FGFR2
37response to organic substanceGO:001003310.7CCND1, CDH1, PTEN, TGFBR2
38lung developmentGO:003032410.7CTNNB1, EGFR, FGFR2, TGFBR2
39cellular response to DNA damage stimulusGO:000697410.7CCND1, MLH1, MLH3, MSH2, TP53
40positive regulation of MAP kinase activityGO:004340610.7EGF, EGFR, ERBB2, KRAS
41regulation of cell motilityGO:200014510.7EGF, EGFR, ERBB2
42reciprocal meiotic recombinationGO:000713110.7MLH1, MLH3, MSH2, MSH3, MSH6
43positive regulation of transcription, DNA-templatedGO:004589310.6CDH1, CTNNB1, EGF, ESR1, ESR2, TP53
44MAPK cascadeGO:000016510.6EGF, EGFR, ERBB2, FGFR2, KRAS
45response to estradiolGO:003235510.5CCND1, CTNNB1, EGFR, ESR1, PTEN
46positive regulation of ERK1 and ERK2 cascadeGO:007037410.4EGFR, ESR1, ESR2, FGFR2, PTEN
47learning or memoryGO:000761110.4EGFR, ESR2, PTEN
48response to drugGO:004249310.3CCND1, CDH1, CTNNB1, PTEN, TGFBR2
49positive regulation of cell proliferationGO:000828410.1CCND1, CTNNB1, EGF, EGFR, FGFR2, KRAS
50positive regulation of transcription from RNA polymerase II promoterGO:00459449.9CTNNB1, EGFR, ESR1, ESR2, FGFR2, PGR

Molecular functions related to Endometrial Cancer according to GeneCards Suite gene sharing:

(show all 29)
idNameGO IDScoreTop Affiliating Genes
1dinucleotide repeat insertion bindingGO:003218111.3MSH2, MSH3
2single thymine insertion bindingGO:003214311.3MSH2, MSH6
3single guanine insertion bindingGO:003214211.2MSH2, MSH3, MSH6
4RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA bindingGO:003805211.2ESR1, ESR2
5dinucleotide insertion or deletion bindingGO:003213911.2MSH2, MSH3
6estrogen receptor activityGO:003028411.2ESR1, ESR2
7oxidized purine DNA bindingGO:003235711.2MSH2, MSH3, MSH6
8guanine/thymine mispair bindingGO:003213711.2MLH1, MSH2, MSH3, MSH6
9estrogen response element bindingGO:003405611.2ESR1, ESR2
10MutLalpha complex bindingGO:003240511.2MSH2, MSH6
11mismatched DNA bindingGO:003098311.1MLH3, MSH2, MSH3, MSH6
12centromeric DNA bindingGO:001923711.1MLH3, MSH2
13nitric-oxide synthase regulator activityGO:003023511.1EGFR, ESR1
14steroid hormone receptor activityGO:000370711.1ESR1, ESR2, PGR
15core promoter sequence-specific DNA bindingGO:000104611.0ESR1, ESR2, TP53
16phosphatidylinositol-4,5-bisphosphate 3-kinase activityGO:004693411.0EGF, EGFR, ERBB2, FGFR2, PIK3CA
17steroid bindingGO:000549611.0ESR1, ESR2, PGR
18damaged DNA bindingGO:000368411.0MSH2, MSH3, MSH6, TP53
19protein tyrosine kinase activityGO:000471311.0EGF, EGFR, ERBB2, FGFR2
20single-stranded DNA bindingGO:000369710.9MLH1, MLH3, MSH2, MSH3
21Ras guanyl-nucleotide exchange factor activityGO:000508810.9EGF, EGFR, ERBB2, FGFR2
22protein phosphatase bindingGO:001990310.9CTNNB1, EGFR, ERBB2, TP53
23ATPase activityGO:001688710.9MLH1, MLH3, MSH2, MSH6
24double-stranded DNA bindingGO:000369010.8CTNNB1, EGFR, MSH2, MSH6, TP53
25chromatin bindingGO:000368210.5CTNNB1, EGFR, ESR1, MLH1, MLH3, MSH6
26protein kinase bindingGO:001990110.5CCND1, CTNNB1, EGFR, MSH2, PTEN, TP53
27ATP bindingGO:000552410.5EGFR, ERBB2, FGFR2, MLH1, MLH3, MSH2
28enzyme bindingGO:001989910.3CCND1, CTNNB1, EGFR, ESR1, ESR2, MSH2
29protein bindingGO:00055159.8CCND1, CDH1, CTNNB1, EGF, EGFR, ERBB2

Sources for Endometrial Cancer

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet